Biotech · Private company · Peachtree Corners, GA, US

Kasa Bio, L.L.C.

Track this companyFree. Adds Kasa Bio, L.L.C. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

A probe-based higher order multiplex technology to expand the capacity of digital PCR systemsFiscal year 2025 · $345.3KNIH RePORTER 1R43GM160998-01 · fetched Nov 12, 2026
A novel and inexpensive multiplex miRNA platform for liver diseases screeningFiscal year 2024 · $274KNIH RePORTER 1R43AA031448-01 · fetched Nov 12, 2026
A multiplex platform for quantitative analysis of clinically important gene expression signaturesFiscal year 2024 · $297.5KNIH RePORTER 1R43GM155903-01A1 · fetched Nov 12, 2026
A multiplex platform for quantitative analysis of clinically important gene expression signaturesFiscal year 2024 · $13KNIH RePORTER 3R43GM155903-01A1S1 · fetched Nov 12, 2026